To evaluate the clinicopathological and imaging features of mammography, ultrasonography, and magnetic resonance imaging (MRI) for breast cancer in Korean women under 40 years of age according to molecular subtypes.
INTRODUCTION
Breast cancer is the most common cancer and is the leading cause of cancer death among women worldwide, accounting for 23% of all new cancer cases and 14% of all cancer deaths (1) .
Approximately 7% to 9% of all breast cancers are diagnosed in women under 40 years of age, and less than 4% are found in women under 35 (1) . The median age of breast cancer patients in Asia is lower than that in Western countries, and the proportion of young breast cancer patients is much higher. Breast cancer in young women accounts for up to 4.8% of cancers diagnosed in Western countries, but more than 10% of cancers diagnosed in Asian countries (2, 3) .
Breast cancer in young women generally has biological features indicating a more aggressive tumor, including a more advanced tumor stage, more aggressive subtypes, and higher histological grades than in older women, and these characteristics are correlated with an increased risk of death (2) (3) (4) . Breast cancer in young women is more likely to be associated with family history and gene mutations, such as BRCA mutations, than in older breast cancer patients (5) . Moreover, young women with breast cancer have higher local recurrence rates after either breast-conserving surgery or mastectomy compared to older women (6 40 years of age tended to receive delayed diagnoses, which could be related to the more advanced stage presentations of this population (7, 8) . Moreover, it is possible that a limited availability of cancer surveillance programs may cause delayed diagnosis, although this stance is controversial (9) .
Many studies have reported an increase in the proportion of breast tumors with hormone receptor (HR) negativity and upregulated human epidermal growth factor receptor 2 (HER2) in young women (10 
MATERIALS AND METHODS

Patient Selection
Our Institutional Review Board approved this retrospective study, and the informed consent requirement was waived. A review of the medical records of patients treated between January 2012 and November 2014 at our institution revealed 1618 consecutive women who had been diagnosed with breast carcinoma. Among these patients, 184 (11.4%) women younger than 40 years who had undergone preoperative breast imaging were included in our study. Among these patients, 8 women who underwent an excisional biopsy for diagnosis before imaging were excluded. Hence, 183 lesions from 176 patients were analyzed in our study. Two radiologists retrospectively reviewed the image characteristics and reported their findings after arriving at a consensus.
They had 10 and 2 years of experience, respectively, and knew that the patients had been diagnosed with breast cancer, but were blind to the immunohistochemical subtypes.
Histopathological Analysis
The histological results were classified as invasive ductal carcinoma (IDC), ductal carcinoma in situ (DCIS), both IDC and DCIS (IDC + DCIS), infiltrating lobular carcinoma, or others.
The pathology report of each surgical specimen was used as the ing and Data System (ACR-BI-RADS 5th edition) (14) . The lesions were described as masses (for which size, shape, margin, and density were reported), calcification (for which size, shape, and distribution were reported), or asymmetry or architectural distortions (for which sizes were reported).
US
US examinations were performed on all 183 lesions using high-resolution ultrasound equipment (12-MHz electronically focused linear array transducer, iU22; Philips Healthcare, Bothell, WA, USA), and the lesions were reviewed retrospectively.
The shapes, margins, orientations, echo patterns, and posterior features of the lesions were described according to the ACR-BI-RADS 5th edition lexicon and classifications.
MRI
Preoperative bilateral breast MRIs were performed on 178 lesions and were retrospectively reviewed. Each patient underwent MRI with a 3T system (Achieva 3T TX or Ingenia 3T CX;
Philips Medical Systems, Best, the Netherlands) with a dedicat- 
Statistical Analysis
The relationships between all image findings and molecular subtypes were statistically evaluated using the SPSS software (version 20.0; SPSS Inc., Chicago, IL, USA 
RESULTS
Clinicopathological Data
All 183 lesions in 176 patients with breast cancer were included in the analysis (Table 1) . Seven patients had bilateral breast cancers at the time of diagnosis. The median age of the patients (Table 1) , luminal A was the most common (43%) (Fig. 1) , followed by TN (24%) (Fig. 2) , luminal B (23%), and HER2-enriched (10%) (Fig. 3) .
Mammography
The most common mammographic feature was a mass with or without calcification (66%) ( Table 2 ). Two thirds of masses (64%)
were of a high density, of which a majority had irregular shapes (89%); a plurality (45%) had indistinct margins. TN type cancer frequently showed as a mass with or without calcification (83%) compared to the other types (p = 0.019). Thirty-six percent of luminal type A tumors showed indistinct margins (Fig. 1A) , while 85% of HER2-enriched type tumors did so, which was significantly higher than in other tumor types (p = 0.006). Sole calcification accounted for 18% of tumors.
US
Most breast cancers (98%) were depicted as masses with or without calcification (Table 3) . Irregular shapes (86%) and indistinct margins (40%) were the most common sonographic findings irrespective of the immunohistochemical subtype. The tumor showed as a mass with a circumscribed margin in 21% of TN cases, which was more than in any of the other types. However, this was not statistically significant (Fig. 2B ). More than half (52%) of the breast cancer masses showed as a hypoechoic lesions on the US overall. However, HER2-enriched type cancer more often showed a heterogeneous echo pattern (44%) than a hypoechoic pattern (33%) (Fig. 3B) . The TN type was found with a posterior enhancement more frequently (49%) than the other immunohistochemical subtypes (p < 0.001) ( Table 3) .
MRI
The breast cancers were most commonly depicted as an enhancing mass (80%), with an irregular shape (83%), and irregular margin (56%). The TN type cancer more commonly showed as a mass (93%) when compared to the other types, but this was not statistically significant ( Table 4 ). The degree of background parenchymal enhancement showed an even distribution among all breast cancers and showed no significant differences by tumor types (p < 0.133). Regarding the internal enhancement patterns, a heterogeneous enhancement was the most common (44%).
However, the rim enhancement pattern was the most common finding in TN type tumors (55%, p < 0.001) (Fig. 2C ).
DISCUSSION
In this study, we analyzed the clinicopathological and molecular subtypes in young women (under 40 years of age) with breast carcinoma. Most (86%) patients showed self-or clinically-detected symptoms, such as lumps or discharge. Eighty percent of asymptomatic patients were diagnosed with breast cancer by US was similar in proportion to that previously reported in older and younger women (11, 17) .
Regarding the clinicopathologic correlation, 30% of the DCIS lesions were asymptomatic whereas only 12% of invasive cancers with or without DCIS were so. Given the high percentages of high-grade and invasive carcinomas in our cohort, concern of unfavorable diagnoses and poor prognoses of breast cancers in younger patients are valid. In many countries, asymptomatic women under 40 years of age are usually not recommended for mammographic breast cancer screening due to the possible hazards of regular exposure to radiation and cost-benefit issues related to having dense breast tissue (18) . Furthermore, the Ko- (8) 11 (14) 1 (3) showed calcifications when including the mass with calcification, and this was consistent with a previous report (20) .
An US showed a very high sensitivity (98%) for cancer detection, which is consistent with previous reports (21) . Only 4 lesions showed negative findings on US, 3 of which corresponded to sole calcification while 1 showed as a mass with calcification on mammography. Three of these lesions manifested as nonmass enhancements on MRI, and 1 did not undergo MRI. When we consider the correlation between the sonographic findings and molecular subtypes, it is similar to those found in a previous study for all age groups (22) . Hormonal receptor negative subtypes, especially the TN subtype, showed more frequent posterior enhancement compared to luminal subtypes on US (23).
The most common abnormal findings on MRI were masses (80%), followed by non-mass enhancements (18%), and foci (2%). In a previous study, young patients under 35 years of age were more likely to display a round/oval or lobular mass shape, a smooth mass margin, and a high signal intensity on T2-weighted images when compared to the relatively older patient group of 35 to 45 year-olds (24) . However, our series showed that only 17% of lesions had round or oval shapes, and 29% had circumscribed margins. Our findings were similar to the results for the older age group (35 to 45 year-olds) in the previous study. However, given the age range of our cohort, there was substantial overlap in the ages of the both groups that were compared. Additionally, TN tumors commonly showed rim enhancement in our study, as in a previous study (25) .
Our retrospective study complements many previous studies regarding multimodality imaging findings of breast cancer in two ways. First, the correlation of the imaging features that we observed with certain molecular subtypes was consistent with those reported in other papers. For example, HER2-enriched subtypes more frequently showed indistinct margins than the other subtypes on mammography, and HR-negative subtypes, especially TN, showed more frequent posterior enhancement compared to luminal subtypes on US. Moreover, as stated above, TN tumors commonly showed rim enhancement on MRI. These specific imaging features will enable the identification of molecular subtypes and will be useful in predicting patients' prognoses. Second, our study showed a similar distribution of breast cancer subtypes in younger patients as that for older patients in previous reports. In our study, young Korean women were more likely to present luminal A type tumors, as is the case with older patients. However, we also observed relatively more prevalent TN type tumors in young patients than in older individuals, as did previous studies with Korean populations (11, 26) . Tumors in young women were more likely to be present with advanced disease and to be of a high grade.
Our study has some limitations, mainly due to its retrospective design and relatively small number of patients. Awareness of known breast cancer patients may have affected the diagnostic sensitivities of the mammography, US, and MRI. In addition, a comparison with an older patient cohort for the same time period would have been helpful to more accurately characterize young breast cancer patients. We also did not include sporadic or genetic information, although breast cancer in young patients raises suspicion of BRCA mutations. In fact, we routinely recommend BRCA testing for young women with breast cancer.
However, BRCA information was not available in our electronic medical records.
In conclusion, young women with breast cancer in Korea were more likely to present the luminal A type. The imaging and pathologic characteristics of breast cancer in women under 40 years of age were similar to those of older counterparts, as has been previously reported. However, TN type tumors were relatively more prevalent than those previously reported for older patients, and tumors in young women were more likely to be present with advanced disease and to be of a high grade.
